Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease (Q38602706)

4 September 2017

title

Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

4 September 2017

0 references

1 reference

Bashar Aqel

1

1 reference

4 September 2017

John K DiBaise

series ordinal

2

1 reference

4 September 2017

language of work or name

1 reference

8 October 2015

1 reference

Nutrition in Clinical Practice

4 September 2017

published in

1 reference

4 September 2017

volume

30

1 reference

4 September 2017

issue

6

1 reference

4 September 2017

page(s)

780-786

1 reference

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Nonalcoholic fatty liver disease in lean individuals in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Patatin-like phospholipase domain-containing 3 and the pathogenesis and progression of pediatric nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

The human microbiome project

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Enterotypes of the human gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Inflammasomes in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Gut microbiota and the pathogenesis of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Effects of gut microbes on nutrient absorption and energy regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Molecular analysis of the bacterial microbiota in the human stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Fructose consumption as a risk factor for non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Sugar-sweetened beverage, diet soda, and fatty liver disease in the Framingham Heart Study cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Sterile inflammation in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Inflammasomes: far beyond inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Chylomicrons promote intestinal absorption of lipopolysaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Metabolic endotoxemia initiates obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Intestinal microbiota in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

VSL#3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Experimental bariatric surgery in rats generates a cytotoxic chemical environment in the gut contents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615605811

21 January 2018

Identifiers

DOI

10.1177/0884533615605811

1 reference

4 September 2017

1 reference